Evidence map›Paper›PMID 26156831›Full record

ArticleBMC gastroenterology2015

High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7.

Aaron R Huber, Dongfeng Tan, Jun Sun, David Dean, Tongtong Wu, Zhongren Zhou

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Signaling pathways and targeted interventions for precancers.Signal transduction and targeted therapy · 2026
    Review
  2. Bioinformatic-based mechanism identification ofJournal of gastrointestinal oncology · 2022
    Article
  3. miR-7/TGF-Acta pharmaceutica Sinica. B · 2022
    Article
  4. Article
  5. Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.Virchows Archiv : an international journal of pathology · 2018
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Aaron R HuberDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY, 14642, USA. AHuber@pathgroup.com.
Dongfeng TanDepartment of Pathology, MD Anderson Cancer Institute, Houston, TX, USA. dtan@mail.mdanderson.org.
Jun SunBiochemistry, Rush University Medical Center, Chicago, IL, USA. jun_sun@rush.edu.
David DeanDepartment of Pediatrics, University of Rochester, Rochester, NY, USA. David_dean@urmc.rochester.edu.
Tongtong WuDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA. Tongtong_Wu@URMC.Rochester.edu.
Zhongren ZhouDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY, 14642, USA. David_Zhou@urmc.rochester.edu.
University of Rochester · USUniversity of Rochester Medical Center · USRush University Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
6 · The paper itself

Abstract

backgroundCarbonic anhydrase IX (CA9) is a transmembrane glycoprotein related to hypoxia. Increased CA9 expression has been associated with decreased survival and cancer progression and has been targeted as a potential therapy for several cancers, including esophageal cancer. The reported percentages of expression of CA9 in esophageal adenocarcinoma vary, and CA9 expression in precancerous esophageal lesions has not been well studied.

methodsIn this study, we investigated CA9 expression in esophageal cancers and in precancerous lesions and explored the association of CA9 expression with prognostic factors and with stem cell and tumorigenesis-related markers including BMI1, cyclin E, ki67, MCM4 and MCM7 expression. Previously constructed tissue microarrays consisting of samples of 7 tissue types (columnar cell metaplasia, Barrett esophagus, low- and high-grade dysplasia, esophageal adenocarcinoma, squamous epithelium, and squamous cell carcinoma) were used for the immunostaining of CA9, BMI1, cyclin E, Ki67, MCM4 and MCM7. RESULTS AND DISCUSSION: CA9 high expression occurred more frequently in glandular mucosa with or without dysplasia than in squamous epithelium or squamous cell carcinoma. Survival duration of esophageal adenocarcinoma did not significantly differ between patients with high CA9 expression and those with low expression. High CA9 expression is significantly associated with BMI1, cyclin E, Ki67, MCM4 and MCM7 expression.

conclusionsHigh CA9 expression may be related to the acidic environment caused by gastroesophageal reflux disease in the gastroesophageal junction and associated with tumorigenesis through BMI1, MCM4 and MCM7.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAntigens, NeoplasmBiomarkers, TumorCarbonic Anhydrase IXCarbonic AnhydrasesCarcinogenesisCarcinoma, Squamous CellCyclin EEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagogastric JunctionFemaleGastroesophageal RefluxAntigens, NeoplasmBiomarkers, TumorBMI1 protein, humanCA9 protein, humanCarbonic Anhydrase IXCarbonic AnhydrasesCyclin EKi-67 AntigenMCM4 protein, humanMCM7 protein, humanMinichromosome Maintenance Complex Component 4Minichromosome Maintenance Complex Component 7Polycomb Repressive Complex 1

Identifiers

PMID26156831
PMCPMC4495619
OpenAlexW1594399600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.